Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

CD70 expression in thymic carcinoma.

Hishima T, Fukayama M, Hayashi Y, Fujii T, Ooba T, Funata N, Koike M.

Am J Surg Pathol. 2000 May;24(5):742-6.

PMID:
10800994
4.

CD5 expression in thymic carcinoma.

Hishima T, Fukayama M, Fujisawa M, Hayashi Y, Arai K, Funata N, Koike M.

Am J Pathol. 1994 Aug;145(2):268-75.

5.
6.

Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.

Hishima T, Fukayama M, Hayashi Y, Fujii T, Arai K, Shiozawa Y, Funata N, Koike M.

Hum Pathol. 1998 Apr;29(4):330-8.

PMID:
9563781
7.

Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.

Pan CC, Chen PC, Chou TY, Chiang H.

Hum Pathol. 2003 Nov;34(11):1155-62.

PMID:
14652817
8.

A case of Epstein-Barr Virus (EBV)-associated thymic carcinoid and investigation of existence of EBV-infected cells in thymus and thymic tumors.

Takeuchi H, Fujita H, Iwasaki F, Takeuchi T, Imadome K, Okumiya T, Matsui T, Takahashi M.

J Clin Microbiol. 2004 Jun;42(6):2850-4.

9.

The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.

Chan JK, Tsang WY, Seneviratne S, Pau MY.

Am J Surg Pathol. 1995 Oct;19(10):1115-23.

PMID:
7573670
10.

EBER-1 expression in thymic carcinoma.

Fujii T, Kawai T, Saito K, Fukushima K, Hasegawa T, Tokunaga M, Yokoyama T.

Acta Pathol Jpn. 1993 Mar;43(3):107-10.

PMID:
8387236
11.

In situ localization of Epstein-Barr virus in thymic carcinoma.

Mann RB, Wu TC, MacMahon EM, Ling Y, Charache P, Ambinder RF.

Mod Pathol. 1992 Jul;5(4):363-6.

PMID:
1323108
12.

Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms.

Nakajima J, Takamoto S, Oka T, Tanaka M, Takeuchi E, Murakawa T.

Eur J Cardiothorac Surg. 2000 Sep;18(3):287-92.

PMID:
10973537
13.

L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

J Surg Oncol. 2009 Jun 1;99(7):433-8. doi: 10.1002/jso.21277.

PMID:
19347882
14.

Expression of neurotrophin receptors in surgically resected thymic epithelial tumors.

Kim DJ, Yang WI, Kim SH, Park IK, Chung KY.

Eur J Cardiothorac Surg. 2005 Oct;28(4):611-6.

PMID:
16125946
15.

Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.

Pan CC, Chen PC, Wang LS, Lee JY, Chiang H.

Histopathology. 2003 Aug;43(2):165-72.

PMID:
12877732
16.

KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas.

Pan CC, Chen PC, Chiang H.

J Pathol. 2004 Mar;202(3):375-81.

PMID:
14991904
18.

MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma.

Kaira K, Murakami H, Serizawa M, Koh Y, Abe M, Ohde Y, Takahashi T, Kondo H, Nakajima T, Yamamoto N.

Virchows Arch. 2011 May;458(5):615-20. doi: 10.1007/s00428-011-1041-x. Epub 2011 Jan 21.

PMID:
21253760
19.

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.

Li J, Zhang XS, Xie D, Deng HX, Gao YF, Chen QY, Huang WL, Masucci MG, Zeng YX.

Cancer Biol Ther. 2007 Dec;6(12):1997-2004. Epub 2007 Oct 13.

PMID:
18087217

Supplemental Content

Support Center